Clinical Trial Update: Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

This document reports completion of a Phase 2 trial evaluating nivolumab plus the AVD chemotherapy regimen in patients with early-stage unfavorable classical Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Dacarbazine (dacarbazine)
• Vinblastine (vinblastine)
• nivolumab (nivolumab)

Snippet

Sponsor: University of Cologne | Conditions: Classical Hodgkin Lymphoma | Phase 2 | Status: COMPLETED